Pfizer Sells Stake in Hisun JV in China
By

By
Pfizer has sold its 49% equity share in its joint venture, Hisun-Pfizer Pharmaceuticals, to Sapphire I (HK) Holdings. Pfizer and Zhejiang Hisun Pharmaceuticals, a Chinese pharmaceutical company, launched the joint…

J&J, Zymeworks Partner for Bispecific Antibodies in $1-Billion-Plus Deal
By

By
Janssen Biotech, one of the pharmaceutical companies of Johnson & Johnson, has signed a license agreement worth up to $1.4 billion with Zymeworks, a Vancouver, Canada-headquartered clinical-stage biopharmaceutical company. Under…

Sanofi, Principia Biopharma in MS, CNS Drug Pact Worth up to $805 Million
By

By
Sanofi has partnered with Principia Biopharma, a South San Francisco, California-based clinical-stage biopharmaceutical company, to develop an experimental oral treatment for multiple sclerosis (MS) and other potential treatments for central…

President Trump Nominates New Head of HHS
By

By
President Donald J. Trump has nominated Alex Michael Azar II, a former executive of Eli Lilly and Company, to be the Secretary of the US Department of Health & Human…

FDA Commissioner Outlines Ways to Improve the Generic-Drug Review Process
By

By
US Food and Drug Administration Commissioner Scott Gottlieb has outlined the agency’s approach to increasing generic-drug competition by prioritizing generic drug reviews and addressing potential misuse of the Risk Evaluation…

DowDuPont Announces Plan for $3 Billion in Cost-Cutting Post Mega Merger
By

By
DowDuPont, the combined company of The Dow Chemical Company and DuPont, following the completion of the companies’ merger in August 2017, announced actions to achieve a $3-billion cost synergy target…

DowDuPont Completes Business Swap for FMC’s Health and Nutrition Business
By

By
DowDuPont, the newly combined company of The Dow Chemical Company and DuPont, has closed on a previously announced business swap with FMC Corporation under which FMC is acquiring a portion…

Amgen Plans R&D Staff Reductions
By

By
Amgen plans to reduce its research and development (R&D) staff by approximately 200 positions by the end of 2017 across R&D sites as part of organizational changes. The staff reductions…

Roche Plans Staff Reductions
By

By
Roche plans to reduce staff at two of its manufacturing facilities, one in Vacaville, California, and one in Kaiseraugst, Switzerland. The company will cut 130 workers from its biologics manufacturing…

EMA Gets Ready for Relocation Decision
By

By
The European Medicines Agency (EMA) has updated the agency’s progress with its relocation to a new host city in the wake of the UK’s decision to exit the European Union…